These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. L-Dopa treatment in Parkinson's Disease. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969 [No Abstract] [Full Text] [Related]
27. [Side effects occurring in the course of treatment of parkinsonism with L-dopa]. Kuran W Neurol Neurochir Pol; 1973; 7(4):587-94. PubMed ID: 4583001 [No Abstract] [Full Text] [Related]
28. L-Dopa and Parkinsonism. Calne DB; Sandler M Nature; 1970 Apr; 226(5240):21-4. PubMed ID: 4907560 [No Abstract] [Full Text] [Related]
29. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor. Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Fehling C; Bell MA N Engl J Med; 1972 Jan; 286(1):8-14. PubMed ID: 4550085 [No Abstract] [Full Text] [Related]
30. [Current treatment of Parkinson syndrome with L-dopa]. Gerstendbrand F; Gründig E; Musiol A Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002 [No Abstract] [Full Text] [Related]
31. Psychiatric side effects of levodopa in man. Goodwin FK JAMA; 1971 Dec; 218(13):1915-20. PubMed ID: 5000569 [No Abstract] [Full Text] [Related]
32. Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis. Chase TN; Holden EM; Brody JA Arch Neurol; 1973 Nov; 29(5):328-33. PubMed ID: 4743883 [No Abstract] [Full Text] [Related]
33. Injected apomorphine and orally administered levodopa in Parkinsonism. Düby SE; Cotzias GC; Papavasiliou PS; Lawrence WH Arch Neurol; 1972 Dec; 27(6):474-80. PubMed ID: 4563448 [No Abstract] [Full Text] [Related]
34. [Therapy and problems of parkinsonism]. Albert E Nervenarzt; 1971 May; 42(5):225-41. PubMed ID: 4942900 [No Abstract] [Full Text] [Related]
35. [Treatment of Parkinson's disease with L-dopa]. Guglielmi L; Vecchi L Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328 [No Abstract] [Full Text] [Related]
36. Long-term effects of levodopa in the severely disabled patient. Sacks OW; Messeloff CR; Schwartz WF JAMA; 1970 Sep; 213(13):2270. PubMed ID: 5468938 [No Abstract] [Full Text] [Related]
38. Levodopa in the treatment of Parkinsonism. Cotzias GC JAMA; 1971 Dec; 218(13):1903-8. PubMed ID: 5171066 [No Abstract] [Full Text] [Related]
39. Combined L-dopa and amantadine in Parkinsonism. Pollock M; Jorgensen PB Aust N Z J Med; 1972 Aug; 2(3):252-5. PubMed ID: 4564049 [No Abstract] [Full Text] [Related]